A detailed history of Russell Investments Group, Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 128,469 shares of IONS stock, worth $4.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128,469
Previous 132,736 3.21%
Holding current value
$4.84 Million
Previous $6.33 Million 18.65%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$40.06 - $51.86 $170,936 - $221,286
-4,267 Reduced 3.21%
128,469 $5.15 Million
Q2 2024

Aug 08, 2024

SELL
$36.45 - $47.7 $753,749 - $986,388
-20,679 Reduced 13.48%
132,736 $6.33 Million
Q1 2024

May 08, 2024

SELL
$42.03 - $53.55 $184,385 - $234,923
-4,387 Reduced 2.78%
153,415 $6.65 Million
Q4 2023

Feb 05, 2024

BUY
$43.39 - $51.63 $3.12 Million - $3.71 Million
71,807 Added 83.5%
157,802 $7.98 Million
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $1.05 Million - $1.29 Million
-27,335 Reduced 24.12%
85,995 $3.9 Million
Q2 2023

Aug 10, 2023

BUY
$34.73 - $43.33 $342,229 - $426,973
9,854 Added 9.52%
113,330 $4.65 Million
Q1 2023

May 09, 2023

SELL
$33.58 - $41.2 $2.92 Million - $3.58 Million
-86,822 Reduced 45.62%
103,476 $3.7 Million
Q4 2022

Feb 08, 2023

BUY
$37.12 - $46.52 $3.64 Million - $4.56 Million
97,978 Added 106.13%
190,298 $7.19 Million
Q3 2022

Nov 04, 2022

SELL
$36.54 - $48.66 $252,637 - $336,435
-6,914 Reduced 6.97%
92,320 $4.08 Million
Q2 2022

Jul 29, 2022

SELL
$31.71 - $43.0 $5.86 Million - $7.95 Million
-184,896 Reduced 65.07%
99,234 $3.67 Million
Q1 2022

May 05, 2022

BUY
$29.88 - $37.04 $2.69 Million - $3.33 Million
89,985 Added 46.35%
284,130 $10.5 Million
Q4 2021

Jan 21, 2022

SELL
$25.61 - $35.1 $966,009 - $1.32 Million
-37,720 Reduced 16.27%
194,145 $5.91 Million
Q3 2021

Nov 08, 2021

BUY
$33.54 - $40.55 $345,830 - $418,111
10,311 Added 4.65%
231,865 $7.77 Million
Q2 2021

Aug 04, 2021

BUY
$34.54 - $47.25 $6.58 Million - $9.01 Million
190,623 Added 616.28%
221,554 $8.84 Million
Q1 2021

May 10, 2021

SELL
$42.51 - $63.78 $1.45 Million - $2.18 Million
-34,128 Reduced 52.46%
30,931 $1.39 Million
Q4 2020

Feb 08, 2021

SELL
$45.3 - $60.27 $405,344 - $539,295
-8,948 Reduced 12.09%
65,059 $3.68 Million
Q3 2020

Nov 09, 2020

SELL
$47.45 - $62.95 $347,523 - $461,045
-7,324 Reduced 9.01%
74,007 $3.51 Million
Q2 2020

Aug 05, 2020

BUY
$46.85 - $61.05 $901,581 - $1.17 Million
19,244 Added 31.0%
81,331 $4.79 Million
Q1 2020

May 06, 2020

BUY
$41.6 - $63.4 $1.66 Million - $2.53 Million
39,963 Added 180.63%
62,087 $2.94 Million
Q4 2019

Jan 29, 2020

SELL
$53.85 - $65.27 $25,094 - $30,415
-466 Reduced 2.06%
22,124 $1.33 Million
Q3 2019

Nov 01, 2019

SELL
$59.06 - $72.15 $80,380 - $98,196
-1,361 Reduced 5.68%
22,590 $1.35 Million
Q2 2019

Aug 09, 2019

BUY
$62.09 - $86.14 $494,236 - $685,674
7,960 Added 49.78%
23,951 $1.54 Million
Q1 2019

May 13, 2019

BUY
$52.92 - $81.17 $204,429 - $313,559
3,863 Added 31.85%
15,991 $1.3 Million
Q1 2018

May 11, 2018

SELL
$44.08 - $55.05 $7,802 - $9,743
-177 Reduced 1.44%
12,128 $535,000
Q3 2017

Nov 07, 2017

BUY
$45.56 - $59.57 $560,615 - $733,008
12,305
12,305 $624,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.